Sleep like never before: Patanjali’s ayurvedic rituals for ultimate rest
Discover Ayurvedic sleep rituals inspired by Patanjali for a restful night. Learn how herbal teas, self-massage, and mindful practices promote better sleep and relaxation.
The Patanjali Ayurved Ltd issued a press release in connection with the media report from Haridwar on Tuesday.
Ramdev’s Patanjali Ayurved has described the recent media report about their company’s health drink failing the test of United States Food and Drug Administration (USFDA) bogus. Terming it a conspiracy of anti-national forces, Patanjali Ayurved elaborated that foreign and anti-national companies frequently make effort to malign Patanjali without any basis or concrete evidence.
The Patanjali Ayurved Ltd issued a press release in connection with the media report from Haridwar on Tuesday. The company states, “Misleading news has been spread in print and social media, recently which suggests that US Food and Drug Administration (USFDA) has found differential claims and qualities for Patanjali’s health drink (sharbat) for India and USA markets. This is a gross misrepresentation of the facts with the only intention to defame Patanjali Ayurved’s image and to mislead its consumers, at large.”
Advertisement
The company claimed that no ban has been imposed on its product in the US and they continue to follow the norms. Providing clarification the company adds, “Patanjali follow the full compliance for packaging and labelling for its products, as per Ayurvedic norms in India, and as per US specific regulations in the USA. These are in the complete compliance of prevailing laws of respective countries. Since the USFDA audit in 2018 till date, the Patanjali Ayurved has not received any notice pertaining to above different claims on ‘Sharbat’ from the US Food and Drug Administration, Nor Patanjali Sharbat’s sale has been banned.”
Advertisement
Advertisement